MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,490,547 | -32.3% | 6,887,996 | -0.5% | 0.00% | 0.0% |
| Q2 2023 | $31,763,185 | -8.6% | 6,920,084 | -1.4% | 0.00% | 0.0% |
| Q1 2023 | $34,752,273 | -6.6% | 7,020,661 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $37,210,348 | -11.2% | 6,815,082 | +5.7% | 0.00% | 0.0% |
| Q3 2022 | $41,912,000 | +56.5% | 6,447,943 | +13.9% | 0.00% | 0.0% |
| Q2 2022 | $26,787,000 | -29.6% | 5,663,419 | +4.0% | 0.00% | 0.0% |
| Q1 2022 | $38,052,000 | -28.4% | 5,443,837 | +4.4% | 0.00% | 0.0% |
| Q4 2021 | $53,135,000 | +541.0% | 5,214,464 | +668.1% | 0.00% | – |
| Q3 2021 | $8,290,000 | – | 678,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |